About SSV Pharma
SSV Pharma is a company based in Hyderabad (India) founded in 2019. It operates as a B2B. The company has 132 employees. SSV Pharma operates in a competitive market with competitors including Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
- Headquarter Hyderabad, India
- Employees 132
- SectorsHealthcare
- Email••••••••
- Website ssvpharma.in
- Legal Name Ssv Pharma Private Limited
- Date of Incorporation 22 Aug, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹23.39 Cr
FY 2023 · +119% YoY
- Net Loss-₹4.51 Cr
FY 2023 · -19% margin
- EBITDA₹3.47 Cr
FY 2023 · 15% margin
- Employee Count132
Associated legal entities of SSV Pharma
SSV Pharma operates through Ssv Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ssv Pharma Private Limited CIN U24305TG2016PTC111579 | Active | 22 Aug 2016 | Hyderabad, Telangana | ₹23.4 Cr | 132 | 5 | View details |
Board of directors of Ssv Pharma Private Limited (SSV Pharma)
Ssv Pharma Private Limited is the primary company behind SSV Pharma. The board of Ssv Pharma Private Limited currently have 5 directors; the longest-serving is Gorantla Venkateswara Rao, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gorantla Venkateswara Rao DIN 01271025 | Director | 22 Aug 2016 | 10 yrs 1 mo | Ssv Pharma Private Limited |
| Gorantla Subhashini DIN 01271067 | Director | 22 Aug 2016 | 10 yrs 1 mo | Ssv Pharma Private Limited |
| Sai Phanendra Gorantla DIN 07593764 | Director | 22 Aug 2016 | 10 yrs 1 mo | Ssv Pharma Private Limited |
| Sridevi Talluri DIN 02905278 | Director | 02 Dec 2020 | 5 yrs 10 mo | Ssv Pharma Private Limited |
| Talluri Srinivasa Rao DIN 07390802 | Director | 21 Feb 2022 | 4 yrs 7 mo | Ssv Pharma Private Limited |
Financials of SSV Pharma
Figures of Ssv Pharma Private Limited, the primary company behind SSV Pharma, for FY 2023. Revenue was ₹23.39 Cr (+119% year on year). Net loss was -₹4.51 Cr (-19% margin). EBITDA was ₹3.47 Cr (15% margin).
- ₹23.39 CrRevenue · FY 2023 · +119% YoY
- -₹4.51 CrNet loss · -19% margin
- ₹3.47 CrEBITDA · 15% margin
- ₹22.30 CrPaid-up capital
- 132Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Ssv Pharma Private Limited are on its company page.
Detailed financial statements for SSV Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of SSV Pharma
SSV Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Lonza, Pfizer, Boehringer Ingelheim and LabConnect, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmaron.com | 2003 | Beijing, China | $320M | 476 | Drug discovery and development services for small molecules are provided. | |
| lonza.com | 1897 | Basel, Switzerland | $100,000 | 14,500 | CDMO services for pharma, biotech, and specialty ingredients are provided. | |
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| boehringer-ingelheim.com | 1885 | – | – | 31 | Generic drugs and clinical research services are provided globally. | |
| labconnect.com | 2002 | Johnson, United States | $28.5M | – | Laboratory testing, clinical trial research, and biopharma services are provided. | |
| ainos.com | 1986 | San Diego, United States | – | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. | |
| biomatter.ai | 2018 | Vilnius, Lithuania | $7.73M | – | Provider of synthetic biology and AI-based technology for generative protein design | |
| betadrugslimited.com | 2005 | Panchkula, India | – | 637 | Developer of therapeutics for oncology and dermatology | |
| evergreentgn.com | 2019 | Jersey, United States | $75.91M | – | Radiopharmaceutical manufacturing and regulatory services are provided. |
Detailed competitors of SSV Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to SSV Pharma
10 companies that operate in the same segment as SSV Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SSV Pharma
SSV Pharma was founded in 2019.
SSV Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
SSV Pharma has 132 employees.
The primary company behind SSV Pharma, Ssv Pharma Private Limited, reported revenue of ₹23.39 Cr for FY 2023, up 119% year on year.
SSV Pharma, based in Hyderabad, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api intermediates and cdmocro. SSV Pharma is a contract manufacturing organization specializing in API intermediates and offering CDMO and CRO services. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
SSV Pharma operates through Ssv Pharma Private Limited.
The legal entities of SSV Pharma currently have 5 directors, including Sridevi Talluri, Gorantla Venkateswara Rao, Gorantla Subhashini and others.